4.7 Article

The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

Alberto Serrano-Pozo et al.

Summary: The APOE ε4 allele and ε2 allele are respectively the strongest genetic risk factor and protective factor for Alzheimer's disease. While therapies targeting APOE are currently unavailable, recent research has expanded our understanding of APOE pathogenesis to include multiple pathological processes, offering valuable insights for therapy development.

LANCET NEUROLOGY (2021)

Article Neurosciences

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Tim West et al.

Summary: The development of a high-resolution mass spectrometry-based plasma biomarker test shows strong diagnostic performance in distinguishing brain amyloid status for Alzheimer's disease and may enhance the efficiency of enrolling participants into AD drug trials.

MOLECULAR NEURODEGENERATION (2021)

Review Neurosciences

Blood-based molecular biomarkers for Alzheimer's disease

Henrik Zetterberg et al.

MOLECULAR BRAIN (2019)

Article Clinical Neurology

Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report

R. Bateman et al.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Review Medicine, Research & Experimental

Update on biomarkers for amyloid pathology in Alzheimer's disease

Nicholas J. Ashton et al.

BIOMARKERS IN MEDICINE (2018)

Article Medicine, Research & Experimental

Amyloid blood biomarker detects Alzheimer's disease

Andreas Nabers et al.

EMBO MOLECULAR MEDICINE (2018)

Article Multidisciplinary Sciences

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Akinori Nakamura et al.

NATURE (2018)

Review Clinical Neurology

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Chia-Chan Liu et al.

NATURE REVIEWS NEUROLOGY (2013)

Review Public, Environmental & Occupational Health

Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review

JE Eichner et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)

Article Cardiac & Cardiovascular Systems

Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project

F Schiele et al.

ATHEROSCLEROSIS (2000)